FDA to Review FHC's Premarket Approval Application for Female Condom
Posted on: Thursday, 7 February 2008, 09:01 CST
The Female Health Company has announced that the FDA has accepted to review the premarket approval application of the company's second generation product, FC2 female condom.
The Center for Devices and Radiological Health (CDRH) received Female Health Company's (FHC) PMA on January 8, 2008.
Source: Datamonitor
Related Articles
- Female Health Company Receives FDA Approval for FC2 Female Condom(R)
- The Female Health Company Expands and Extends Its Stock Repurchase Program
- The Female Health Company Schedules First Quarter Conference Call for February 10, 2009
- The Female Health Company Receives USAID | DELIVER PROJECT Order for 8.1 Million Units
- The Female Health Company to Present at Growth and Value Investor Conference in Ft. Lauderdale
- The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
- The Female Health Company Receives USAID | DELIVER PROJECT Order for 5 Million Units
- Female Health Company Appoints Robert Nelson Director, Program and Sales
- The Female Health Company Receives Total USAID Orders Exceeding 8.5 Million Units for 2006; USAID Exercises Contract Option for Incremental Volume
- Female Health Company Names Donna Felch Chief Financial Officer
Rating: 3.1 / 5 (9 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds